Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Jacques Ferlay, Eva Steliarova‐Foucher, Joannie Lortet‐Tieulent et al. · European Journal of Cancer · 2013 · 5.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

Medicine, Oncology, Pathology +11

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text

Medicine, Oncology, Pathology +14

Comprehensive molecular characterization of urothelial bladder carcinoma

Zhenlin Ju · Nature · 2014 · 3.1K citations · Full text

Medicine, Molecular Biology, Oncology +17

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Stuart Pocock, Richard Simon · Biometrics · 1975 · 2.4K citations

Public Health, Biostatistics, Clinical Epidemiology +12